One holding company & subsidiaries

The LFB Group is composed of the LFB S.A. holding company, two French subsidiaries fully owned by LFB S.A., and international subsidiaries.

Both LFB Biomedicaments and LFB Biotechnologies are fully owned subsidiaries of the LFB Group. LFB Biomedicaments specializes in plasma fractionation and the marketing of plasma-derived medicinal products. LFB Biotechnologies focuses on the R&D and biotechnology activities of the group.

The LFB group has several foreign subsidiaries including in Brazil, in Germany and in Great Britain, as in the Middle East.

A limited company with a mainly public capital

The LFB Group, a French bio-pharmaceutical company, has a limited company status with a mainly public capital. The Group is currently fully owned by the French state. The LFB Group is active on a competitive market and bids for hospital tenders like other pharmaceutical companies.